BioCentury
ARTICLE | Company News

Access Pharmaceuticals, Hanmi Pharmaceutical sales and marketing update

March 17, 2014 7:00 AM UTC

Access granted Hanmi exclusive rights to commercialize MuGard in South Korea. Access will receive an undisclosed upfront payment and is eligible to receive double-digit royalties on net sales. The mu...